article thumbnail

Addressing Specialty Pharmacy Adherence Challenges Head On

Omnicell

Sarah Kester, PharmD Pharmaceutical Program Manager, Omnicell Specialty Pharmacy Services Medication non-adherence is a crippling problem in healthcare today, causing unnecessary hospitalizations and escalating costs. 2 Specialty pharmacy is a hotbed for adherence issues.

article thumbnail

Healthcare Dealmakers—Elevance to acquire Kroger Specialty Pharmacy; Optum to buy Steward's physician group and more

Fierce Healthcare

RevSpring switches private equity owners, Tenet sells off more hospitals, a $21 billion healthcare real estate merger and more dealmaking news from the month of March.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma á la carte 04/20/23

The Honest Apothecary

.” Reminds of the classic book by Fred Lee, If Disney Ran Your Hospital. ” Specialty Pharmacy vs. Physician Buy-and-Bill “The study found that drugs were less costly for patients when payers leveraged a specialty pharmacy.”

article thumbnail

STAT+: Pharmalittle: We’re reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more

STAT

using its Accredo specialty pharmacy beginning in June , Reuters writes. While only 8% of hospitalized patients with Covid-19 had bacterial co-infections requiring antibiotics, some 75% of patients have been treated with antibiotics “just in case” they help. monthly list price of Humira.

article thumbnail

NASP 2022 Reveals a Pharmacy Landscape Shifting to Specialty

Omnicell

Kristen Dowd Director, Pharmacy Management Services, Omnicell If the 2022 NASP (National Association of Specialty Pharmacy) Annual Meeting and Expo is any indication, we are approaching a time when specialty pharmacy simply becomes pharmacy – when complex, high-touch biologics become nearly as ubiquitous as their broad-spectrum counterparts.

article thumbnail

Pharma á la carte – 05/04/2023

The Honest Apothecary

Erik Musiek, a Washington University neurologist at Barnes-Jewish Hospital, said the efficacy looks as good or better than lecanemab.”The Adam Fein speaks at Asembia The Drug Channels guru of all things related to the pharmaceutical supply chain, Adam Fein, opines on the future of specialty pharmacy at Asembia.

article thumbnail

Over Two Dozen Posters at the 2023 PQA Annual Meeting

PQA

With that in mind, here’s what will be presented in our poster session and the lead author for each project: A pharmacist-led intervention to optimize inhaler therapy upon hospital discharge.